As of January 22, 2025, Avidity Biosciences (RNA) has a market cap of $3.62 billion USD. According to our data, Avidity Biosciences is ranked No.3191 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $3.62 B |
4.23%
|
Dec 31, 2024 | $3.47 B |
221.33%
|
Dec 29, 2023 | $1.08 B |
-59.22%
|
Dec 30, 2022 | $2.65 B |
-6.65%
|
Dec 31, 2021 | $2.84 B |
-6.86%
|
Dec 31, 2020 | $3.04 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sarepta Therapeutics
SRPT
|
$11.08 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.19 B |
0.000 M
|
USA
|
Wave Life Sciences
WVE
|
$1.72 B |
28.979 M
|
Singapore
|
Dynavax Technologies
DVAX
|
$1.64 B |
-0.022 B
|
USA
|
Arrowhead Pharmaceuticals
ARWR
|
$2.44 B |
-0.021 B
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.39 B |
-0.001 M
|
USA
|
Moderna
MRNA
|
$14.88 B |
0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.81 B |
-0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.37 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.10 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.82 B |
6.828 M
|
Switzerland
|
Intellia Therapeutics
NTLA
|
$1.03 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.00 B |
-0.030 B
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.23 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.02 M |
0.000 M
|
USA
|
Market Cap | = | RNA Stock Price | * | RNA Shares Outstanding |
= | $30.31 | * | 0.12 B | |
= | $3.62 B |